
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $176.4M | -- | -- | $1.49 | -- |
07/24/2025 | Q2 | $185.1M | -- | -- | $1.67 | -- |
04/22/2025 | Q1 | $259.3M | $218.2M | $3.11 | $2.78 | $0.33 |
01/21/2025 | Q4 | $173.3M | $123.7M | $1.29 | $1.24 | $0.05 |
10/23/2024 | Q3 | $168.1M | $133.9M | $1.35 | $1.41 | -$0.06 |
07/24/2024 | Q2 | $176.6M | $140.2M | $1.66 | $1.55 | $0.11 |
04/24/2024 | Q1 | $240.6M | $202.9M | $2.56 | $2.35 | $0.21 |
01/24/2024 | Q4 | $166.4M | $128M | $1.06 | $1.24 | -$0.18 |
10/25/2023 | Q3 | -- | -- | $1.36 | $1.25 | $0.11 |
07/26/2023 | Q2 | -- | -- | $1.68 | $1.47 | $0.21 |
04/26/2023 | Q1 | -- | -- | $1.99 | $2.02 | -$0.03 |
01/25/2023 | Q4 | -- | -- | $0.98 | $0.81 | $0.18 |
10/27/2022 | Q3 | -- | -- | $0.81 | $0.71 | $0.11 |
07/27/2022 | Q2 | -- | -- | $0.76 | $0.92 | -$0.16 |
04/28/2022 | Q1 | -- | -- | $1.66 | $1.97 | -$0.31 |
01/26/2022 | Q4 | -- | -- | $2.00 | $0.68 | $1.32 |
10/27/2021 | Q3 | -- | -- | $0.50 | $0.81 | -$0.31 |
07/28/2021 | Q2 | -- | -- | $1.21 | $0.89 | $0.32 |
04/27/2021 | Q1 | -- | -- | $1.84 | $1.57 | $0.27 |
01/27/2021 | Q4 | -- | -- | $0.84 | $0.51 | $0.33 |
10/28/2020 | Q3 | -- | -- | $0.38 | $0.18 | $0.20 |
07/22/2020 | Q2 | -- | -- | $0.53 | $0.21 | $0.32 |
04/22/2020 | Q1 | -- | -- | $1.45 | $1.19 | $0.27 |
01/29/2020 | Q4 | -- | -- | $0.56 | $0.50 | $0.06 |
10/24/2019 | Q3 | -- | -- | $0.53 | $0.52 | $0.01 |
07/30/2019 | Q2 | -- | -- | $0.75 | $0.49 | $0.26 |
04/25/2019 | Q1 | -- | -- | $0.81 | $0.87 | -$0.06 |
01/28/2019 | Q4 | -- | -- | $0.39 | -- | -- |
10/30/2018 | Q3 | -- | -- | $0.24 | -- | -- |
07/26/2018 | Q2 | -- | -- | $0.23 | -- | -- |
04/30/2018 | Q1 | -- | -- | $1.08 | -- | -- |
01/30/2018 | Q4 | -- | -- | $0.16 | -- | -- |
10/25/2017 | Q3 | -- | -- | $0.06 | -- | -- |
07/26/2017 | Q2 | -- | -- | $0.35 | -- | -- |
04/26/2017 | Q1 | -- | -- | $1.14 | -- | -- |
01/30/2017 | Q4 | -- | -- | $0.05 | -- | -- |
10/25/2016 | Q3 | -- | -- | $0.23 | -- | -- |
07/25/2016 | Q2 | -- | -- | $0.35 | -- | -- |
04/28/2016 | Q1 | -- | -- | $0.56 | -- | -- |
01/28/2016 | Q4 | -- | -- | $0.16 | -- | -- |
10/30/2015 | Q3 | -- | -- | $0.21 | -- | -- |
Pathward Financial reported $218.2M worth of top line sales in its most recent quarter.
Pathward Financial announced earnings per share of $3.11 which represents a beat of analyst forecast a $2.78 per share.
Pathward Financial reported -- that represents -- per share over the last quarter.
Pathward Financial's earnings are forecast to grow from $6.62 per share to $6.55 per share next year representing an increase of 13.39%.
Pathward Financial's next earnings date is July 24, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.